Page 870 - Small Animal Internal Medicine, 6th Edition
P. 870

842    PART VI   Endocrine Disorders



                   BOX 49.11
  VetBooks.ir  Initial Management of Dogs or Cats With Severe Diabetic Ketoacidosis

             Fluid Therapy
                                                                 Low-dose intravenous infusion technique: To prepare
             Type: 0.9% saline if hyponatremia is severe           infusion, add 2.2 U/kg (dogs) or 1.1 U/kg (cats) of
               (<130 mEq/L); isotonic crystalloid solution such    regular insulin to 250 mL of 0.9% saline; run 50 mL
               as Ringer’s, Ringer’s lactate, Plasma-Lyte 148,     through the drip set and discard; then administer via
               or Normosol-R if serum sodium concentration         infusion or syringe pump through a line separate from
               ≥ 130 mEq/L                                         that used for fluid therapy at an initial rate of 10 mL/h;
             Rate: 60 to 100 mL/kg/24 h initially; adjust based on   adjust infusion rate according to hourly blood glucose
               hydration status, urine output, persistence of fluid losses  measurements; switch to subcutaneous regular insulin
                                              +
             Potassium supplement: Based on serum K  concentration   q6-8h once blood glucose is less than 250 mg/dL, or
               (see Table 53.1); if unknown, initially add 40 mEq of   continue insulin infusion at a decreased rate to prevent
               KCl to each liter of fluids                         hypoglycemia until the insulin preparation is exchanged
             Phosphate supplement: Administer if serum phosphorus   for a longer-acting product.
               concentration < 1.5 mg/dL; initial IV infusion rate is   Goal: Gradual decline in blood glucose concentration,
               0.01 to 0.03 mmol phosphate/kg/h in calcium-free    preferably around 50 mg/dL/h until concentration is
               intravenous fluids                                  less than 250 mg/dL
             Dextrose supplement: Not indicated until blood glucose   Ancillary Therapy
               concentration is less than 250 mg/dL, then begin 5%
               dextrose infusion                                 Concurrent pancreatitis is common in diabetic
                                                                   ketoacidosis; nothing by mouth and aggressive fluid
             Bicarbonate Therapy                                   therapy are usually indicated
             Indication: Administer if plasma bicarbonate concentration   Concurrent infections are common in diabetic ketoacidosis;
               is less than 12 mEq/L or if total venous CO 2       use of broad-spectrum, parenteral antibiotics is usually
               concentration is less than12 mmol/L; if not known, do   indicated
               not administer unless animal is severely ill and then   Additional therapy may be needed, depending on the
               only once.                                          nature of concurrent disorders
             Amount: mEq HCO 3 − = body weight (kg) × 0.4 × (12   Patient Monitoring
                                                  −
               − animal’s HCO 3 ) × 0.5; if animal’s HCO 3  or total
                             −
               CO 2  concentration is unknown, use 10 in place of (12   Blood glucose measurement q1-2h initially; adjust insulin
                             −
               − animal’s HCO 3 )                                  therapy and begin dextrose infusion when decreases to
             Administration: Add to intravenous fluids and give over 6   below 250 mg/dL
               hours; do not give as bolus infusion              Hydration status, respiration, pulse q2-4h; adjust fluids
             Retreatment: Only if plasma bicarbonate concentration   accordingly
               remains less than 12 mEq/L after 6 hours of therapy  Serum electrolyte and total venous CO 2  concentrations
                                                                   q6-12h; adjust fluid and bicarbonate therapy
             Insulin Therapy                                       accordingly
             Type: Regular crystalline insulin                   Urine output, glycosuria, ketonuria q2-4h; adjust fluid
                                                                   therapy accordingly
             Administration Technique                            Body weight, packed cell volume, temperature, and blood
             Intermittent intramuscular technique: Initial dose, 0.1 to   pressure q6-8h
               0.2 U/kg intramuscularly; then 0.1 U/kg           Additional monitoring, depending on concurrent disease
               intramuscularly hourly until blood glucose concentration
               is less than 250 mg/dL; then switch to regular insulin
               administered IM q4-6h or SC q6-8h


            plasma protein concentration; serum glucose, albumin, cre-  FLUID THERAPY
            atinine, and urea nitrogen concentrations; serum electro-  Initiation of appropriate fluid therapy should be the first step
            lytes; venous total CO 2  or arterial acid-base evaluation; and   in the treatment of DKA, and in most cases it should precede
            urine specific gravity. Abnormalities frequently associated   the initiation of insulin therapy by 2 hours or longer to
            with DKA are listed in Box 49.12. Once treatment for DKA   minimize the development of complications affiliated with
            is initiated, additional studies, such as CBC, serum biochem-  insulin administration. Replacement of fluid deficiencies and
            istry panel, urinalysis, urine culture, thoracic radiographs,   maintenance of normal fluid balance are important to ensure
            and abdominal ultrasound, or diagnostic tests for pancreati-  adequate cardiac output, blood pressure, and blood flow to
            tis, diestrus in the female dog, and hyperthyroidism in the   all tissues. Improvement in renal blood flow is especially
            cat are usually warranted to identify underlying concurrent   critical. In addition to the general beneficial aspects of fluid
            disorders (see Box 49.8).                            therapy in any dehydrated animal, fluid therapy can correct
   865   866   867   868   869   870   871   872   873   874   875